Immunohistochemistry in breast tumour specimens has shown that the levels of p-ELK1 expression are significantly elevated in luminal and Her-2-negative BRCA subtypes55, but how Elk1 is activated in BRCA is not known. This evidence concerns the gene ELK1 and breast neoplasm.